Prophylactic Pulmonary Vein Isolation Study

Not Applicable

Terminated

• Conditions: Atrial Fibrillation
• Interventions: Procedure: Pulmonary Vein Isolation

• Registration Number: NCT00587899
• Lead Sponsor: Mayo Clinic

Brief Summary

This study is being done to learn the effects of the Pulmonary Vein Isolation in patients that are at high risk to developing, but do not have a documented history of atrial fibrillation.

Detailed Description

Patients with a dilated left atrium (left upper chamber of the heart) that undergo mitral valve surgery may be at risk for the development of atrial fibrillation after surgery.

Atrial fibrillation (also known as "A-Fib" or AF) is an abnormal heart rhythm which may cause symptoms such as pounding sensations in your chest, dizziness, fatigue, chest pain and/or shortness of breath. AF patients are at a higher risk of developing a stroke.

Participants who sign informed consent will be randomized into one of two groups by chance (as in the flip of a coin).

Approximately 77 patients will undergo their mitral valve operation along with Pulmonary Vein Isolation (a treatment group) and 77 patients who do not undergo Pulmonary Vein Isolation at the time of their mitral valve surgery (a control group).

The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation using a device that delivers radiofrequency energy to the heart muscle in order to create scar tissue to block electrical impulses that can trigger episodes of AF.

The control group of patients will undergo operation for mitral valve disease without the additional Pulmonary Vein Isolation.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2007-01
• Study First Submitted: 2007-12-22
• Study First Submitted QC: 2008-01-07
• Study First Posted: 2008-01-08
• Primary Completion: 2009-11
• Study Completion: 2009-11
• Status Verified: 2011-04
• Last Update Submitted: 2011-04-12
• Last Update Posted: 2011-04-14

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

• Indication for open-heart surgery: Mitral valve repair or replacement, evidence of a dilated left atrium

Read More

Exclusion Criteria

• History of Atrial Fibrillation
• Need for emergent cardiac surgery
• Previous cardiac surgery
• Preoperative need for an intraaortic balloon pump or intravenous inotropes
• Current diagnosis of active endocarditis
• Mental impairment/or experience other conditions which may not allow subject to understand nature
• Significance and scope of study
• Pregnancy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Pulmonary Vein Isolation	The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation.

Primary Outcome Measures

Name	Time	Method
Evaluated by the number of patients free of taking antiarrhythmic medications and free of AF as determined by a 24-hour Holter recording.	12 months

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States